調査レポート | • レポートコード：QYR2104Z4145 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、NGSベースRNA-seqのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ハイスループットシーケンシング、第3世代シーケンシング技術）、用途別市場規模（病院＆診療所、バイオ医薬品企業、政府機関、学術研究機関、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・NGSベースRNA-seqの市場動向 ・企業の競争状況、市場シェア ・NGSベースRNA-seqの種類別市場規模（ハイスループットシーケンシング、第3世代シーケンシング技術） ・NGSベースRNA-seqの用途別市場規模（病院＆診療所、バイオ医薬品企業、政府機関、学術研究機関、その他） ・NGSベースRNA-seqの北米市場規模2016-2027（アメリカ、カナダ） ・NGSベースRNA-seqのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・NGSベースRNA-seqのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・NGSベースRNA-seqの中南米市場規模2016-2027（メキシコ、ブラジル） ・NGSベースRNA-seqの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Illumina、Thermo Fisher Scientific、Pacific Biosciences Of California、Qaigen、F. Hoffmann-La Roche、Agilent Technologies、Oxford Nanopore Technologies、Perkinelmer、Eurofins Scientific、Gatc Biotech、Macrogen） ・結論 |
Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market.
The hospitals and clinics segment is expected to register the highest growth due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics.
Market Analysis and Insights: Global NGS-based RNA-seq Market
The global NGS-based RNA-seq market size is projected to reach US$ 3013.7 million by 2026, from US$ 1409.2 million in 2019, at a CAGR of 11.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global NGS-based RNA-seq market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global NGS-based RNA-seq market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global NGS-based RNA-seq market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global NGS-based RNA-seq market.
Global NGS-based RNA-seq Scope and Market Size
NGS-based RNA-seq market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global NGS-based RNA-seq market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
High-Throughput Sequencing
Third-Generation Sequencing Technology
Segment by Application
Hospitals and Clinics
Biopharma Companies
Government Agencies
Academic and Research Organizations
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Illumina
Thermo Fisher Scientific
Pacific Biosciences Of California
Qaigen
F. Hoffmann-La Roche
Agilent Technologies
Oxford Nanopore Technologies
Perkinelmer
Eurofins Scientific
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NGS-based RNA-seq Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 High-Throughput Sequencing
1.2.3 Third-Generation Sequencing Technology
1.3 Market by Application
1.3.1 Global NGS-based RNA-seq Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and Clinics
1.3.3 Biopharma Companies
1.3.4 Government Agencies
1.3.5 Academic and Research Organizations
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global NGS-based RNA-seq Market Perspective (2016-2027)
2.2 NGS-based RNA-seq Growth Trends by Regions
2.2.1 NGS-based RNA-seq Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 NGS-based RNA-seq Historic Market Share by Regions (2016-2021)
2.2.3 NGS-based RNA-seq Forecasted Market Size by Regions (2022-2027)
2.3 NGS-based RNA-seq Industry Dynamic
2.3.1 NGS-based RNA-seq Market Trends
2.3.2 NGS-based RNA-seq Market Drivers
2.3.3 NGS-based RNA-seq Market Challenges
2.3.4 NGS-based RNA-seq Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NGS-based RNA-seq Players by Revenue
3.1.1 Global Top NGS-based RNA-seq Players by Revenue (2016-2021)
3.1.2 Global NGS-based RNA-seq Revenue Market Share by Players (2016-2021)
3.2 Global NGS-based RNA-seq Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by NGS-based RNA-seq Revenue
3.4 Global NGS-based RNA-seq Market Concentration Ratio
3.4.1 Global NGS-based RNA-seq Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NGS-based RNA-seq Revenue in 2020
3.5 NGS-based RNA-seq Key Players Head office and Area Served
3.6 Key Players NGS-based RNA-seq Product Solution and Service
3.7 Date of Enter into NGS-based RNA-seq Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NGS-based RNA-seq Breakdown Data by Type
4.1 Global NGS-based RNA-seq Historic Market Size by Type (2016-2021)
4.2 Global NGS-based RNA-seq Forecasted Market Size by Type (2022-2027)
5 NGS-based RNA-seq Breakdown Data by Application
5.1 Global NGS-based RNA-seq Historic Market Size by Application (2016-2021)
5.2 Global NGS-based RNA-seq Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America NGS-based RNA-seq Market Size (2016-2027)
6.2 North America NGS-based RNA-seq Market Size by Type
6.2.1 North America NGS-based RNA-seq Market Size by Type (2016-2021)
6.2.2 North America NGS-based RNA-seq Market Size by Type (2022-2027)
6.2.3 North America NGS-based RNA-seq Market Size by Type (2016-2027)
6.3 North America NGS-based RNA-seq Market Size by Application
6.3.1 North America NGS-based RNA-seq Market Size by Application (2016-2021)
6.3.2 North America NGS-based RNA-seq Market Size by Application (2022-2027)
6.3.3 North America NGS-based RNA-seq Market Size by Application (2016-2027)
6.4 North America NGS-based RNA-seq Market Size by Country
6.4.1 North America NGS-based RNA-seq Market Size by Country (2016-2021)
6.4.2 North America NGS-based RNA-seq Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe NGS-based RNA-seq Market Size (2016-2027)
7.2 Europe NGS-based RNA-seq Market Size by Type
7.2.1 Europe NGS-based RNA-seq Market Size by Type (2016-2021)
7.2.2 Europe NGS-based RNA-seq Market Size by Type (2022-2027)
7.2.3 Europe NGS-based RNA-seq Market Size by Type (2016-2027)
7.3 Europe NGS-based RNA-seq Market Size by Application
7.3.1 Europe NGS-based RNA-seq Market Size by Application (2016-2021)
7.3.2 Europe NGS-based RNA-seq Market Size by Application (2022-2027)
7.3.3 Europe NGS-based RNA-seq Market Size by Application (2016-2027)
7.4 Europe NGS-based RNA-seq Market Size by Country
7.4.1 Europe NGS-based RNA-seq Market Size by Country (2016-2021)
7.4.2 Europe NGS-based RNA-seq Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific NGS-based RNA-seq Market Size (2016-2027)
8.2 Asia-Pacific NGS-based RNA-seq Market Size by Type
8.2.1 Asia-Pacific NGS-based RNA-seq Market Size by Type (2016-2021)
8.2.2 Asia-Pacific NGS-based RNA-seq Market Size by Type (2022-2027)
8.2.3 Asia-Pacific NGS-based RNA-seq Market Size by Type (2016-2027)
8.3 Asia-Pacific NGS-based RNA-seq Market Size by Application
8.3.1 Asia-Pacific NGS-based RNA-seq Market Size by Application (2016-2021)
8.3.2 Asia-Pacific NGS-based RNA-seq Market Size by Application (2022-2027)
8.3.3 Asia-Pacific NGS-based RNA-seq Market Size by Application (2016-2027)
8.4 Asia-Pacific NGS-based RNA-seq Market Size by Region
8.4.1 Asia-Pacific NGS-based RNA-seq Market Size by Region (2016-2021)
8.4.2 Asia-Pacific NGS-based RNA-seq Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America NGS-based RNA-seq Market Size (2016-2027)
9.2 Latin America NGS-based RNA-seq Market Size by Type
9.2.1 Latin America NGS-based RNA-seq Market Size by Type (2016-2021)
9.2.2 Latin America NGS-based RNA-seq Market Size by Type (2022-2027)
9.2.3 Latin America NGS-based RNA-seq Market Size by Type (2016-2027)
9.3 Latin America NGS-based RNA-seq Market Size by Application
9.3.1 Latin America NGS-based RNA-seq Market Size by Application (2016-2021)
9.3.2 Latin America NGS-based RNA-seq Market Size by Application (2022-2027)
9.3.3 Latin America NGS-based RNA-seq Market Size by Application (2016-2027)
9.4 Latin America NGS-based RNA-seq Market Size by Country
9.4.1 Latin America NGS-based RNA-seq Market Size by Country (2016-2021)
9.4.2 Latin America NGS-based RNA-seq Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NGS-based RNA-seq Market Size (2016-2027)
10.2 Middle East & Africa NGS-based RNA-seq Market Size by Type
10.2.1 Middle East & Africa NGS-based RNA-seq Market Size by Type (2016-2021)
10.2.2 Middle East & Africa NGS-based RNA-seq Market Size by Type (2022-2027)
10.2.3 Middle East & Africa NGS-based RNA-seq Market Size by Type (2016-2027)
10.3 Middle East & Africa NGS-based RNA-seq Market Size by Application
10.3.1 Middle East & Africa NGS-based RNA-seq Market Size by Application (2016-2021)
10.3.2 Middle East & Africa NGS-based RNA-seq Market Size by Application (2022-2027)
10.3.3 Middle East & Africa NGS-based RNA-seq Market Size by Application (2016-2027)
10.4 Middle East & Africa NGS-based RNA-seq Market Size by Country
10.4.1 Middle East & Africa NGS-based RNA-seq Market Size by Country (2016-2021)
10.4.2 Middle East & Africa NGS-based RNA-seq Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina NGS-based RNA-seq Introduction
11.1.4 Illumina Revenue in NGS-based RNA-seq Business (2016-2021)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific NGS-based RNA-seq Introduction
11.2.4 Thermo Fisher Scientific Revenue in NGS-based RNA-seq Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Pacific Biosciences Of California
11.3.1 Pacific Biosciences Of California Company Details
11.3.2 Pacific Biosciences Of California Business Overview
11.3.3 Pacific Biosciences Of California NGS-based RNA-seq Introduction
11.3.4 Pacific Biosciences Of California Revenue in NGS-based RNA-seq Business (2016-2021)
11.3.5 Pacific Biosciences Of California Recent Development
11.4 Qaigen
11.4.1 Qaigen Company Details
11.4.2 Qaigen Business Overview
11.4.3 Qaigen NGS-based RNA-seq Introduction
11.4.4 Qaigen Revenue in NGS-based RNA-seq Business (2016-2021)
11.4.5 Qaigen Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche NGS-based RNA-seq Introduction
11.5.4 F. Hoffmann-La Roche Revenue in NGS-based RNA-seq Business (2016-2021)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Agilent Technologies
11.6.1 Agilent Technologies Company Details
11.6.2 Agilent Technologies Business Overview
11.6.3 Agilent Technologies NGS-based RNA-seq Introduction
11.6.4 Agilent Technologies Revenue in NGS-based RNA-seq Business (2016-2021)
11.6.5 Agilent Technologies Recent Development
11.7 Oxford Nanopore Technologies
11.7.1 Oxford Nanopore Technologies Company Details
11.7.2 Oxford Nanopore Technologies Business Overview
11.7.3 Oxford Nanopore Technologies NGS-based RNA-seq Introduction
11.7.4 Oxford Nanopore Technologies Revenue in NGS-based RNA-seq Business (2016-2021)
11.7.5 Oxford Nanopore Technologies Recent Development
11.8 Perkinelmer
11.8.1 Perkinelmer Company Details
11.8.2 Perkinelmer Business Overview
11.8.3 Perkinelmer NGS-based RNA-seq Introduction
11.8.4 Perkinelmer Revenue in NGS-based RNA-seq Business (2016-2021)
11.8.5 Perkinelmer Recent Development
11.9 Eurofins Scientific
11.9.1 Eurofins Scientific Company Details
11.9.2 Eurofins Scientific Business Overview
11.9.3 Eurofins Scientific NGS-based RNA-seq Introduction
11.9.4 Eurofins Scientific Revenue in NGS-based RNA-seq Business (2016-2021)
11.9.5 Eurofins Scientific Recent Development
11.10 Gatc Biotech
11.10.1 Gatc Biotech Company Details
11.10.2 Gatc Biotech Business Overview
11.10.3 Gatc Biotech NGS-based RNA-seq Introduction
11.10.4 Gatc Biotech Revenue in NGS-based RNA-seq Business (2016-2021)
11.10.5 Gatc Biotech Recent Development
11.11 Macrogen
11.11.1 Macrogen Company Details
11.11.2 Macrogen Business Overview
11.11.3 Macrogen NGS-based RNA-seq Introduction
11.11.4 Macrogen Revenue in NGS-based RNA-seq Business (2016-2021)
11.11.5 Macrogen Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global NGS-based RNA-seq Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of High-Throughput Sequencing
Table 3. Key Players of Third-Generation Sequencing Technology
Table 4. Global NGS-based RNA-seq Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global NGS-based RNA-seq Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global NGS-based RNA-seq Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global NGS-based RNA-seq Market Share by Regions (2016-2021)
Table 8. Global NGS-based RNA-seq Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global NGS-based RNA-seq Market Share by Regions (2022-2027)
Table 10. NGS-based RNA-seq Market Trends
Table 11. NGS-based RNA-seq Market Drivers
Table 12. NGS-based RNA-seq Market Challenges
Table 13. NGS-based RNA-seq Market Restraints
Table 14. Global NGS-based RNA-seq Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global NGS-based RNA-seq Market Share by Players (2016-2021)
Table 16. Global Top NGS-based RNA-seq Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NGS-based RNA-seq as of 2020)
Table 17. Ranking of Global Top NGS-based RNA-seq Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by NGS-based RNA-seq Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players NGS-based RNA-seq Product Solution and Service
Table 21. Date of Enter into NGS-based RNA-seq Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global NGS-based RNA-seq Market Size by Type (2016-2021) (US$ Million)
Table 24. Global NGS-based RNA-seq Revenue Market Share by Type (2016-2021)
Table 25. Global NGS-based RNA-seq Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global NGS-based RNA-seq Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global NGS-based RNA-seq Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global NGS-based RNA-seq Revenue Market Share by Application (2016-2021)
Table 29. Global NGS-based RNA-seq Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global NGS-based RNA-seq Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America NGS-based RNA-seq Market Size by Type (2016-2021) (US$ Million)
Table 32. North America NGS-based RNA-seq Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America NGS-based RNA-seq Market Size by Application (2016-2021) (US$ Million)
Table 34. North America NGS-based RNA-seq Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America NGS-based RNA-seq Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America NGS-based RNA-seq Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe NGS-based RNA-seq Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe NGS-based RNA-seq Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe NGS-based RNA-seq Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe NGS-based RNA-seq Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe NGS-based RNA-seq Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe NGS-based RNA-seq Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific NGS-based RNA-seq Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific NGS-based RNA-seq Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific NGS-based RNA-seq Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific NGS-based RNA-seq Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific NGS-based RNA-seq Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific NGS-based RNA-seq Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America NGS-based RNA-seq Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America NGS-based RNA-seq Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America NGS-based RNA-seq Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America NGS-based RNA-seq Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America NGS-based RNA-seq Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America NGS-based RNA-seq Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa NGS-based RNA-seq Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa NGS-based RNA-seq Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa NGS-based RNA-seq Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa NGS-based RNA-seq Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa NGS-based RNA-seq Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa NGS-based RNA-seq Market Size by Country (2022-2027) & (US$ Million)
Table 61. Illumina Company Details
Table 62. Illumina Business Overview
Table 63. Illumina NGS-based RNA-seq Product
Table 64. Illumina Revenue in NGS-based RNA-seq Business (2016-2021) & (US$ Million)
Table 65. Illumina Recent Development
Table 66. Thermo Fisher Scientific Company Details
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific NGS-based RNA-seq Product
Table 69. Thermo Fisher Scientific Revenue in NGS-based RNA-seq Business (2016-2021) & (US$ Million)
Table 70. Thermo Fisher Scientific Recent Development
Table 71. Pacific Biosciences Of California Company Details
Table 72. Pacific Biosciences Of California Business Overview
Table 73. Pacific Biosciences Of California NGS-based RNA-seq Product
Table 74. Pacific Biosciences Of California Revenue in NGS-based RNA-seq Business (2016-2021) & (US$ Million)
Table 75. Pacific Biosciences Of California Recent Development
Table 76. Qaigen Company Details
Table 77. Qaigen Business Overview
Table 78. Qaigen NGS-based RNA-seq Product
Table 79. Qaigen Revenue in NGS-based RNA-seq Business (2016-2021) & (US$ Million)
Table 80. Qaigen Recent Development
Table 81. F. Hoffmann-La Roche Company Details
Table 82. F. Hoffmann-La Roche Business Overview
Table 83. F. Hoffmann-La Roche NGS-based RNA-seq Product
Table 84. F. Hoffmann-La Roche Revenue in NGS-based RNA-seq Business (2016-2021) & (US$ Million)
Table 85. F. Hoffmann-La Roche Recent Development
Table 86. Agilent Technologies Company Details
Table 87. Agilent Technologies Business Overview
Table 88. Agilent Technologies NGS-based RNA-seq Product
Table 89. Agilent Technologies Revenue in NGS-based RNA-seq Business (2016-2021) & (US$ Million)
Table 90. Agilent Technologies Recent Development
Table 91. Oxford Nanopore Technologies Company Details
Table 92. Oxford Nanopore Technologies Business Overview
Table 93. Oxford Nanopore Technologies NGS-based RNA-seq Product
Table 94. Oxford Nanopore Technologies Revenue in NGS-based RNA-seq Business (2016-2021) & (US$ Million)
Table 95. Oxford Nanopore Technologies Recent Development
Table 96. Perkinelmer Company Details
Table 97. Perkinelmer Business Overview
Table 98. Perkinelmer Revenue in NGS-based RNA-seq Business (2016-2021) & (US$ Million)
Table 99. Perkinelmer Recent Development
Table 100. Eurofins Scientific Company Details
Table 101. Eurofins Scientific Business Overview
Table 102. Eurofins Scientific NGS-based RNA-seq Product
Table 103. Eurofins Scientific Revenue in NGS-based RNA-seq Business (2016-2021) & (US$ Million)
Table 104. Eurofins Scientific Recent Development
Table 105. Gatc Biotech Company Details
Table 106. Gatc Biotech Business Overview
Table 107. Gatc Biotech NGS-based RNA-seq Product
Table 108. Gatc Biotech Revenue in NGS-based RNA-seq Business (2016-2021) & (US$ Million)
Table 109. Gatc Biotech Recent Development
Table 110. Macrogen Company Details
Table 111. Macrogen Business Overview
Table 112. Macrogen NGS-based RNA-seq Product
Table 113. Macrogen Revenue in NGS-based RNA-seq Business (2016-2021) & (US$ Million)
Table 114. Macrogen Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NGS-based RNA-seq Market Share by Type: 2020 VS 2027
Figure 2. High-Throughput Sequencing Features
Figure 3. Third-Generation Sequencing Technology Features
Figure 4. Global NGS-based RNA-seq Market Share by Application: 2020 VS 2027
Figure 5. Hospitals and Clinics Case Studies
Figure 6. Biopharma Companies Case Studies
Figure 7. Government Agencies Case Studies
Figure 8. Academic and Research Organizations Case Studies
Figure 9. Other Case Studies
Figure 10. NGS-based RNA-seq Report Years Considered
Figure 11. Global NGS-based RNA-seq Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global NGS-based RNA-seq Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global NGS-based RNA-seq Market Share by Regions: 2020 VS 2027
Figure 14. Global NGS-based RNA-seq Market Share by Regions (2022-2027)
Figure 15. Global NGS-based RNA-seq Market Share by Players in 2020
Figure 16. Global Top NGS-based RNA-seq Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NGS-based RNA-seq as of 2020
Figure 17. The Top 10 and 5 Players Market Share by NGS-based RNA-seq Revenue in 2020
Figure 18. Global NGS-based RNA-seq Revenue Market Share by Type (2016-2021)
Figure 19. Global NGS-based RNA-seq Revenue Market Share by Type (2022-2027)
Figure 20. North America NGS-based RNA-seq Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America NGS-based RNA-seq Market Share by Type (2016-2027)
Figure 22. North America NGS-based RNA-seq Market Share by Application (2016-2027)
Figure 23. North America NGS-based RNA-seq Market Share by Country (2016-2027)
Figure 24. United States NGS-based RNA-seq Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada NGS-based RNA-seq Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe NGS-based RNA-seq Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe NGS-based RNA-seq Market Share by Type (2016-2027)
Figure 28. Europe NGS-based RNA-seq Market Share by Application (2016-2027)
Figure 29. Europe NGS-based RNA-seq Market Share by Country (2016-2027)
Figure 30. Germany NGS-based RNA-seq Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France NGS-based RNA-seq Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. NGS-based RNA-seq Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy NGS-based RNA-seq Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia NGS-based RNA-seq Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic NGS-based RNA-seq Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific NGS-based RNA-seq Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific NGS-based RNA-seq Market Share by Type (2016-2027)
Figure 38. Asia-Pacific NGS-based RNA-seq Market Share by Application (2016-2027)
Figure 39. Asia-Pacific NGS-based RNA-seq Market Share by Region (2016-2027)
Figure 40. China NGS-based RNA-seq Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan NGS-based RNA-seq Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea NGS-based RNA-seq Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia NGS-based RNA-seq Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India NGS-based RNA-seq Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia NGS-based RNA-seq Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America NGS-based RNA-seq Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America NGS-based RNA-seq Market Share by Type (2016-2027)
Figure 48. Latin America NGS-based RNA-seq Market Share by Application (2016-2027)
Figure 49. Latin America NGS-based RNA-seq Market Share by Country (2016-2027)
Figure 50. Mexico NGS-based RNA-seq Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil NGS-based RNA-seq Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa NGS-based RNA-seq Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa NGS-based RNA-seq Market Share by Type (2016-2027)
Figure 54. Middle East & Africa NGS-based RNA-seq Market Share by Application (2016-2027)
Figure 55. Middle East & Africa NGS-based RNA-seq Market Share by Country (2016-2027)
Figure 56. Turkey NGS-based RNA-seq Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia NGS-based RNA-seq Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE NGS-based RNA-seq Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Illumina Revenue Growth Rate in NGS-based RNA-seq Business (2016-2021)
Figure 60. Thermo Fisher Scientific Revenue Growth Rate in NGS-based RNA-seq Business (2016-2021)
Figure 61. Pacific Biosciences Of California Revenue Growth Rate in NGS-based RNA-seq Business (2016-2021)
Figure 62. Qaigen Revenue Growth Rate in NGS-based RNA-seq Business (2016-2021)
Figure 63. F. Hoffmann-La Roche Revenue Growth Rate in NGS-based RNA-seq Business (2016-2021)
Figure 64. Agilent Technologies Revenue Growth Rate in NGS-based RNA-seq Business (2016-2021)
Figure 65. Oxford Nanopore Technologies Revenue Growth Rate in NGS-based RNA-seq Business (2016-2021)
Figure 66. Perkinelmer Revenue Growth Rate in NGS-based RNA-seq Business (2016-2021)
Figure 67. Eurofins Scientific Revenue Growth Rate in NGS-based RNA-seq Business (2016-2021)
Figure 68. Gatc Biotech Revenue Growth Rate in NGS-based RNA-seq Business (2016-2021)
Figure 69. Macrogen Revenue Growth Rate in NGS-based RNA-seq Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の次世代シーケンシング（NGS）データ分析市場規模・現状・予測（2021年-2027年） North America is home to several well-established organizations of NGS data analysis. A significant number of NGS research projects are being carried out in Canadian universities, which in turn has resulted into huge demand for NGS data analysis, thereby affecting the revenue growth in the region. N…- 世界の次世代シーケンシング情報市場規模・現状・予測（2021年-2027年） Next-Generation Sequencing Informatics, also known as High-throughput sequencing, is marked by the ability to sequence one hundred thousand to one million DNA molecules in parallel, often with short readings. Market Analysis and Insights: Global Next-Generation Sequencing Informatics Market The glob…
- 世界のハイスループットスクリーニング技術市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global High-throughput Screening Technology Market The global High-throughput Screening Technology market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and h…
- 世界のRNAメチル化シークエンス市場規模・現状・予測（2021年-2027年） RNA methylation is a common phenomenon in both eukaryotes and prokaryotes, which plays a crucial role in regulating multipal biological processes. Antibodies, bisulfite are two most used ingredients to help the sequencing, and contribute to obtain the sequence information and transcripts expression …
- 世界のシングルセルゲノムシーケンシング技術市場規模・現状・予測（2021年-2027年） Single-Cell Genome Sequencing Technology is a new technology to amplify and sequence the whole genome at the single cell level. The principle is to amplify a small amount of genomic DNA from isolated single cells, obtain high-coverage complete genomes, and then perform high-throughput sequencing to …